Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 63, Issue 12, Pages 2230-2239
Publisher
Wiley
Online
2016-07-19
DOI
10.1002/pbc.26147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune cell subsets at birth may help to predict risk of late-onset sepsis and necrotizing enterocolitis in preterm infants
- (2016) Konrad Bochennek et al. EARLY HUMAN DEVELOPMENT
- Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy
- (2016) Eva Rettinger et al. HAEMATOLOGICA
- Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy
- (2016) Eva Rettinger et al. HAEMATOLOGICA
- Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus
- (2015) Verena Pfirrmann et al. CYTOTHERAPY
- Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion
- (2014) Eva Rettinger et al. CYTOTHERAPY
- Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation
- (2013) E Rettinger et al. BONE MARROW TRANSPLANTATION
- Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor
- (2013) Sarah Tettamanti et al. BRITISH JOURNAL OF HAEMATOLOGY
- IL-15 Improves the Cytotoxicity of Cytokine-induced Killer Cells Against Leukemia Cells by Upregulating CD3+CD56+ Cells and Downregulating Regulatory T Cells As Well As IL-35
- (2013) Qianshan Tao et al. JOURNAL OF IMMUNOTHERAPY
- Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
- (2013) Ulrike Koehl et al. Frontiers in Oncology
- Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
- (2012) M Stern et al. BONE MARROW TRANSPLANTATION
- Natural killer cells can exert a graft-vs-tumor effect in haploidentical stem cell transplantation for pediatric solid tumors
- (2012) Antonio Pérez-Martínez et al. EXPERIMENTAL HEMATOLOGY
- NK cytotoxicity and alloreactivity against neuroblastoma cell lines in vitro: Comparison of Europium fluorometry assay and quantification by RT-PCR
- (2012) C. Paillard et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Neuroblastoma
- (2012) Andrew M. Davidoff Seminars in Pediatric Surgery
- Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
- (2012) Dario Sangiolo Journal of Cancer
- Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models
- (2012) Eva Rettinger et al. Frontiers in Oncology
- Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation
- (2011) Ginna G. Laport et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
- (2011) A. Pievani et al. BLOOD
- The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies
- (2011) Y-C Linn et al. BONE MARROW TRANSPLANTATION
- The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells
- (2011) Eva Rettinger et al. CYTOTHERAPY
- Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells
- (2011) E. Distler et al. HAEMATOLOGICA
- NK Cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT
- (2011) Justyna Kanold et al. PEDIATRIC BLOOD & CANCER
- Reduced-intensity allogeneic stem cell transplantation for children with neuroblastoma who failed tandem autologous stem cell transplantation
- (2011) Ki Woong Sung et al. PEDIATRIC BLOOD & CANCER
- IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
- (2011) Claudia Brehm et al. PLoS One
- IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
- (2010) Stephan Kloess et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation
- (2010) S. Kuci et al. HAEMATOLOGICA
- Cytokine-Induced NK-Like T Cells: From Bench to Bedside
- (2010) Yeh Ching Linn et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Iodine-131-Metaiodobenzylguanidine with Haploidentical Stem Cell Transplantation and Posttransplant Immunotherapy in Children with Relapsed/Refractory Neuroblastoma
- (2009) Jacek Toporski et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes
- (2009) Marta Franceschetti et al. EXPERIMENTAL HEMATOLOGY
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
- (2008) R. Nishimura et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now